Latest Options News

Astral Resources has released a compelling Pre-Feasibility Study for its Mandilla Gold Project in Western Australia, outlining a 19-year mine life with robust economics and a maiden ore reserve of 1.1 million ounces. The study sets the stage for a Definitive Feasibility Study targeted for mid-2026.

GreenTech Metals has announced a substantial copper-zinc Exploration Target at its Whundo Project, signaling potential for near-term mining operations. The company is accelerating assessments of gold contributions and advancing mining studies to unlock value.

Dateline Resources’ Managing Director Stephen Baghdadi has exercised over 53 million options, injecting more than $1 million into the company and increasing his shareholding to nearly 13%. This capital boost aims to accelerate exploration and development at the promising Colosseum Gold and Rare Earth Elements Project in California.

Xero Limited has announced a binding agreement to acquire Melio Limited for US$2.5 billion, backed by a fully underwritten A$1.85 billion equity raise. This strategic move aims to accelerate Xero’s US growth and more than double its FY25 revenue by FY28.

Xero Limited has agreed to acquire Melio Limited, a leading US SMB bill pay platform, for US$2.5 billion, marking a significant leap in its US growth strategy. The deal is backed by a substantial A$1.85 billion equity raise and aims to accelerate revenue and market presence by FY28.

Eildon Capital has launched a new Dividend and Distribution Reinvestment Plan (DRP) offering Australian and New Zealand securityholders a cost-free way to reinvest distributions into additional stapled securities. The plan provides flexible participation options and detailed governance to support investor choice and capital growth.

Eildon Capital Group has announced the reactivation of its Dividend and Distribution Reinvestment Plan (DRP) for the upcoming half-year distribution, offering securityholders a cost-free way to reinvest dividends into additional securities.

archTIS Limited addresses ASX concerns over a sharp rise in its share price, linking the movement to recent contract wins in major defence markets and ongoing acquisition talks in the US.

Biotron Limited has completed the initial safety phase of its lead Hepatitis B drug in animal studies, paving the way for efficacy testing in two distinct mouse models. This milestone marks a significant step forward in the company’s antiviral drug development program.

Adherium Limited has announced an accelerated non-renounceable entitlement offer to raise approximately A$4 million, issuing new shares and options to fund expansion and product development. The offer includes a Top-Up Facility and is partially underwritten, signaling a strategic push to scale its respiratory monitoring technology.

Adherium Limited is raising up to $4 million through a partially underwritten entitlement offer to expand its US digital health platform and recruit key personnel. The capital raise supports scaling patient onboarding and advancing its FDA-cleared smart inhaler technology.

American West Metals has completed a A$14 million funding round, including a share purchase plan, to accelerate exploration and feasibility studies at its Storm Project. The company is now fully funded to pursue drilling programs targeting copper resources and new discoveries.